At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Sorted Descending Type Shares Traded Price Range
May 30, 2007 crowley john f Officer Statement of Ownership 0 n/a
Jun 21, 2007 crowley john f Officer Option Execute 33,736 0.64
Dec 13, 2007 crowley john f Officer Option Execute 10,000 0.64
Dec 14, 2007 crowley john f Officer Option Execute 5,000 0.64
Jan 2, 2008 crowley john f Officer Automatic Sell 400 10.35
Jan 2, 2008 crowley john f Officer Automatic Sell 9,600 10.13 - 10.67
Jan 2, 2008 crowley john f Officer Option Execute 20,000 0.64
Feb 1, 2008 crowley john f Officer Automatic Sell 10,000 10.00
Feb 29, 2008 crowley john f Officer Option Execute 10,000 0.64
Mar 3, 2008 crowley john f Officer Automatic Sell 4,497 10.00
Mar 4, 2008 crowley john f Officer Automatic Sell 5,503 10.00
Apr 1, 2008 crowley john f Officer Automatic Sell 2,400 10.83 - 11.29
Apr 2, 2008 crowley john f Officer Automatic Sell 5,800 10.86 - 11.25
Apr 3, 2008 crowley john f Officer Automatic Sell 1,800 11.00 - 11.06
May 1, 2008 crowley john f Officer Automatic Sell 5,205 10.34 - 10.88
May 2, 2008 crowley john f Officer Automatic Sell 4,795 10.26 - 10.72
Jun 2, 2008 crowley john f Officer Automatic Sell 1,300 10.12 - 10.29
Jun 3, 2008 crowley john f Officer Automatic Sell 3,700 10.08 - 10.44
Jun 4, 2008 crowley john f Officer Automatic Sell 5,000 10.29 - 10.50
Jul 1, 2008 crowley john f Officer Automatic Sell 3,300 10.62 - 10.79
Showing 1-20 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy